With one of the largest footprints in biotech, Cowen sets the standard for thought leadership and impactful strategic advice.
Research capabilities for
the Biotech sector
Cowen’s biotech team has one of the largest research footprints in the space, covering companies pioneering the treatment of diseases. Our analysts’ work has been validated in third-party polls, such as Institutional Investor’s All-America Research Team, the Greenwich Associates poll, and Starmine. In addition to company-specific research, publications such as Biotechnology Quarterly have become legend among investors. Similarly, our Ahead Of The Curve™ reports are at the center of conversation.
Numerous biotechnology reports make use of Cowen’s extensive network of clinicians to help our analysts guage market potential for therapeutics options. We have also created proprietary programs as needed to support our analysts’ research.
Our annual Health Care Conference remains one of Wall Street’s most highly regarded, and is the epicenter of discussion for corporate executives, institutional investors, venture capitalists, and health care professionals. We also host annually the Cowen Therapeutics Conference that provides an ideal forum for objective, first-hand views on both marketed and emerging therapeutics.
Ritu BaralManaging Director, Health Care - Biotechnology646 562 1379
Phil Nadeau, Ph.D.Managing Director, Health Care - Biotechnology646 562 1336
Boris Peaker, Ph.D., CFAManaging Director, Health Care - Biotechnology646 562 1377
Eric Schmidt, Ph.D.Managing Director, Health Care - Biotechnology646 562 1345
Chris Shibutani, MDManaging Director, Health Care - Biotechnology617 946 3733
Investment Banking capabilities for
the Biotech sector
Cowen is a leading bank for high quality financings and financial advisory for life sciences companies. The biotech investment banking team combines the global resources and full service product capabilities of a leading financial institution with the focus and commitment of a specialty investment banking firm.
We have proven track record of providing impactful strategic advice and a superior ability to execute debt and equity transactions as well mergers and acquisitions. We understand our clients’ unique challenges and opportunities and deliver the entire organization to help clients’ achieve their goals.
George MilsteinManaging Director and Head, Health Care415 646 7394
Tanya JosephManaging Director, Health Care646 562 1109
Jamie StreatorManaging Director, Health Care646 562 1148
Chris SwindleManaging Director, Health Care415 646 7393
Rob WeirManaging Director, Health Care415 646 7392
Jeff UrlichDirector, Health Care415 646 7395
Head of Health Care
D 415 646 7394